Italian Digital Primary Cardiovascular Prevention Study

Plain-language summary

This study looks at how a mobile health application may help with the primary prevention of cardiovascular disease. People aged 45 and older who own a smartphone and have no previous cardiovascular disease may take part. It is a study without an assigned phase and is currently active but not recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Active, not recruiting

Sponsor

Centro Cardiologico Monzino

Intervention

Mobile health application

Start date

6/10/2022

Estimated completion

12/1/2029

Countries

Italy

Related genes

Locations

• Scafa, Italy
• Martano, Italy
• Reggio Calabria, Italy
• Benevento, Italy
• Salerno, Italy
• Salerno, Italy
• Carpi, Italy
• Pradamano, Italy
• Pozzilli, Italy
• Rome, Italy
• Rome, Italy
• Rome, Italy
• Genoa, Italy
• Genoa, Italy
• Appiano Gentile, Italy
• Bergamo, Italy
• Legnano, Italy
• Milan, Italy
• Milan, Italy
• Milan, Italy
• Milan, Italy
• Mozzate, Italy
• Pavia, Italy
• Pavia, Italy
• Rozzano, Italy
• San Donato Milanese, Italy
• Sesto San Giovanni, Italy
• Soresina, Italy
• Palermo, Italy
• Seravezza, Italy
• Siena, Italy
• Padova, Italy

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Subjects aged ≥ 45 years
* Have given their consent to participate in the study
* Subjects who have a smartphone

Exclusion Criteria:

* Current or previous cardiovascular disease (personal history of myocardial infarction, angina pectoris, arterial revascularization procedures, stroke, TIA, peripheral artery disease)
* Psychiatric disorders
* Participation in other clinical trials